ELI LILLY news, videos and press releases
For more news please use our advanced search feature.
ELI LILLY - More news...
ELI LILLY - More news...
-
Earnings Alert: Amazon, Eli Lilly & More
-
Eli Lilly slashes prices of low doses of weight loss drug by scrapping auto-injector
-
Eli Lilly to offer weight loss drug directly to qualifying customers at lower price
- Saving Lives Beyond Medicine With Eli Lilly
- Thinking about buying stock in SoundHound AI, Eli Lilly, Dell Technologies, NKGen Biotech, or Riot Platforms?
- Thinking about trading options or stock in Amazon, Eli Lilly, Altimmune, Novavax, or Snap?
-
Eli Lilly soars on profit outlook, demand for weight-loss drug
- Thinking about trading options or stock in Monday.Com, Boeing, Eli Lilly, Xpeng, or Genmab?
- Thinking about buying stock in Cardio Diagnostics, Eli Lilly, Crowdstrike, NXU Inc., or Gan Ltd?
- Shareholder Alert: Ademi LLP investigates whether POINT Biopharma Global, Inc. has obtained a Fair Price in its transaction with Eli Lilly
-
Eli Lilly Alzheimer’s drug could slow disease, but comes with side effects
- Shareholder Alert: Ademi LLP investigates whether Sigilon Therapeutics, Inc. has obtained a Fair Price in its transaction with Eli Lilly
-
Eli Lilly releases new data from potentially game-changing weight loss drug trial
- The Department of Health - Abu Dhabi and Eli Lilly Suisse S.A sign Declaration of Collaboration to support clinical research and healthcare innovation
- Thinking about trading options or stock in Amazon, Costco, Apple, Eli Lilly, or MicroStrategy?
-
Eli Lilly announces insulin price cut
-
Drugmaker Eli Lilly caps insulin cost at $35 per month
-
Eli Lilly caps out-of-pocket insulin cost at $35 a month
- Shareholder Alert: Ademi LLP investigates whether Akouos, Inc. has obtained a Fair Price in its transaction with Eli Lilly
- Thinking about trading options or stock in General Motors, 3M, Eli Lilly, UnitedHealth, or General Electric?
- Thinking about trading options or stock in New Fortress Energy, Eli Lilly, Tesla, CMS Energy, or Pfizer?
-
Clorox, Under Armour, Eli Lilly: Jim Cramer's Stock Market Breakdown - August 3
- Mirikizumab Up-Regulates Genes Associated with Mucosal Healing in Ulcerative Colitis for Up to One Year in Phase 2 Study
- Lilly Declares Third-Quarter 2021 Dividend
- Lilly's SURPASS-2 results published in The New England Journal of Medicine show tirzepatide achieved superior A1C and body weight reductions compared to injectable semaglutide in adults with type 2 diabetes
- Thinking about trading options or stock in Eli Lilly, Pfizer, GameStop, Cleveland-Cliffs, or FuelCell Energy?
- OLUMIANT® Improved Pain, Physical Function and Morning Joint Stiffness in Rheumatoid Arthritis in Phase 3 Post-Hoc Analyses
- Mirikizumab Improves Fatigue in Patients with Crohn's Disease in Phase 2 Trial
- Lilly's tirzepatide achieves all primary and key secondary study outcomes against insulin glargine in adults with type 2 diabetes and increased cardiovascular risk in SURPASS-4 trial
- Should you invest in Dillard's, Inovio Pharmaceuticals, Eli Lilly, Nektar Therapeutics, or Carnival Corp?
